The DOI matches its Crossref record; 402 of the 402 references it cites were found in a registry or an index.
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 402
Wruck, C. J., Streetz, K. L., Pavic, G., Götz, M. E., Tohidnezhad, M., Brandenburg, L., Varoga, D. J., Eickelberg, O., Herdegen, T., Trautwein, C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162008 · Cited by 144
The role of IL-6 in the radiation response of prostate cancer
Wu, C., Chen, M., Chen, W., & Hsieh, C. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-159 · Cited by 144
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
Takakura, A., Nelson, E. A., Haque, N., Humphreys, B. D., Zandi-Nejad, K., Frank, D. A., & Zhou, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr338 · Cited by 143
Tam, L., McGlynn, L. M., Traynor, P., Mukherjee, R., Bartlett, J. M. S., & Edwards, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603871 · Cited by 143
The many faces of Janus kinase
Seavey, M. M., & Dobrzański, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.024 · Cited by 143
Sultani, M., Stringer, A. M., Bowen, J. M., & Gibson, R. J. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/490804 · Cited by 142
Combinatorial Screenings in Patients
Zurita, A. J., Troncoso, P., Cardó‐Vila, M., Logothetis, C. J., Pasqualini, R., & Arap, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2675 · Cited by 136
Circulating Serum Levels of Cytokines and Angiogenic Factors in Patients with Cervical Cancer
Chopra, V., Dinh, T. V., & Hannigan, E. V. (1998) · Cancer Investigation · doi:10.3109/07357909809050029 · Cited by 135
Rosen, D. G., Mercado‐Uribe, I., Yang, G. S., Bast, R. C., Amin, H. M., Lai, R. L., & Liu, J. (2006) · Cancer · doi:10.1002/cncr.22293 · Cited by 133
IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
Chen, M., Lin, P., Wu, C., Chen, W., & Wu, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061901 · Cited by 132
Maione, D., Carlo, E. D., Li, W., Musiani, P., Modesti, A., Peters, M., Rose‐John, S., Rocca, C. D., Tripodi, M., Lazzaro, D., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5588 · Cited by 128
Mizutani, Y., Bonavida, B., Koishihara, Y., Akamatsu, K., Ohsugi, Y., & Yoshida, O. (1995) · PubMed · Cited by 127
Mano, Y., Aishima, S., Fujita, N., Tanaka, Y., Kubo, Y., Motomura, T., Taketomi, A., Shirabe, K., Maehara, Y., & Oda, Y. (2013) · Pathobiology · doi:10.1159/000346196 · Cited by 126
Interleukin-11 Links Oxidative Stress and Compensatory Proliferation
Nishina, T., Komazawa‐Sakon, S., Yanaka, S., Piao, X., Zheng, D.-M., Piao, J., Kojima, Y., Yamashina, S., Sano, E., Putoczki, T. L., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002056 · Cited by 126
Xu, S., Grande, F., Garofalo, A., & Neamati, N. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1082 · Cited by 125
West, N. R., Murray, J. I., & Watson, P. H. (2013) · Oncogene · doi:10.1038/onc.2013.105 · Cited by 124
Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression
Cb, J., Judd, L. M., Menheniott, T. R., Kronborg, I., Dow, C., Yeomans, N. D., Boussioutas, A., Robb, L. G., & Giraud, A. (2007) · The Journal of Pathology · doi:10.1002/path.2218 · Cited by 122
Nrf2 is a potential therapeutic target in radioresistance in human cancer
Zhou, S., Ye, W., Shao, Q., Zhang, M., & Liang, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.09.001 · Cited by 120
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Thiem, S., Pierce, T. P., Palmieri, M., Putoczki, T. L., Büchert, M., Preaudet, A., Farid, R., Love, C., Catimel, B., Lei, Z., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65086 · Cited by 119
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma
Soresi, M., Giannitrapani, L., D'Antona, F., Florena, A.-M., Spada, E. L., Terranova, A., Cervello, M., D’Alessandro, N., & Montalto, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i16.2563 · Cited by 118
Kim, M., Nam, H.-J., Kim, H., Han, S., Im, S., Kim, T., Oh, D., & Bang, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.010 · Cited by 118
Lin, L., Fuchs, J. R., Li, C., Olson, V., Bekaii‐Saab, T., & Lin, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.112 · Cited by 117
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
Chopra, V., Ding, T. V., & Hanningan, E. V. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01214669 · Cited by 117
Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
Xin, H., Herrmann, A., Reckamp, K. L., Zhang, W., Pal, S. K., Hedvat, M., Zhang, C., Liang, W. P., Scuto, A., Weng, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1217 · Cited by 117
Serum interleukin-6 and -10 levels in patients with gastric cancer
Ikeguchi, M., Hatada, T., Yamamoto, M., Miyake, T., Matsunaga, T., Fukumoto, Y., Yamada, Y., Fukuda, K., Saito, H., & Tatebe, S. (2009) · Gastric Cancer · doi:10.1007/s10120-009-0509-8 · Cited by 116
Interleukin-6 (IL-6) Functions as an Autocrine Growth Factor in Cervical Carcinomas in Vitro
Eustace, D. L. S., Han, X., Gooding, R. P., Rowbottom, A. W., Riches, P., & HEYDERMAN, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1156 · Cited by 115
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma
Jang, J. W., Oh, B. S., Kwon, J. H., You, C. R., Chung, K. W., Kay, C. S., & Jung, H. S. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.017 · Cited by 114
Denley, S. M., Jamieson, N. B., McCall, P., Oien, K. A., Morton, J. P., Carter, C. R., Edwards, J., & McKay, C. J. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2168-7 · Cited by 113
B-Raf and the inhibitors: from bench to bedside
Huang, T., Karsy, M. J., Zhuge, J., Zhong, M., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-30 · Cited by 113
Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell linesin vitro
Okamoto, M., Hattori, K., & Oyasu, R. (1997) · International Journal of Cancer · Cited by 112
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
Cao, Q., Li, Y., He, W., Zhang, Z.-Z., Zhou, Q., Liu, X., Shen, Y., & Huang, T. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00122.2013 · Cited by 110
Hayakawa, F., Sugimoto, K., Harada, Y., Hashimoto, N., Ohi, N., Kurahashi, S., & Naoe, T. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.63 · Cited by 108
IL-17 promoted metastasis of non-small-cell lung cancer cells
Li, Q., Yang, H., Fei, G., Guo, Z., Ren, T., & Liu, Z. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.10.011 · Cited by 107
Signal transducer and activator of transcription 3 inhibitors: a patent review
Page, B. D. G., Ball, D. P., & Gunning, P. T. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.539205 · Cited by 106
Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis
Kinoshita, H., Hirata, Y., Nakagawa, H., Sakamoto, K., Hayakawa, Y., Takahashi, R., Nakata, W., Sakitani, K., Serizawa, T., Hikiba, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060914 · Cited by 106
β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma
Yan, S., Zhou, C., Zhang, W., Zhang, G., Zhao, X., Yang, S., Wang, Y., Lü, N., Zhu, H., & Xu, N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.035 · Cited by 105
Takemoto, S., Ushijima, K., Kawano, K., Yamaguchi, T., Terada, A., Fujiyoshi, N., Nishio, S., Tsuda, N., Ijichi, M., Kakuma, T., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605212 · Cited by 105
Brady Jennifer, J., Li, M., Suthram, S., Jiang, H., Wong, W. H., & Blau, H. M. (2013) · Nature Cell Biology · doi:10.1038/ncb2835 · Cited by 104
Zhang, Y., Du, X., Wang, C., Lin, D., Ruan, X., Feng, Y., Huo, Y., Peng, H., Cui, J., Zhang, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.023 · Cited by 104
Bogani, C., Bartalucci, N., Martinelli, S., Tozzi, L., Guglielmelli, P., Bosi, A., Vannucchi, A. M., & Mieloproliferative, A. I. P. L. R. S. C. A. G. I. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054826 · Cited by 103
Yeoh, G. C., Ernst, M., Rose‐John, S., Akhurst, B., Payne, C. J., Long, S., Alexander, W. S., Croker, B. A., Grail, D., & Matthews, V. B. (2007) · Hepatology · doi:10.1002/hep.21535 · Cited by 103
Cheon, Y. K., Cho, Y. D., Moon, J. H., Jang, J. Y., Kim, Y. S., Kim, Y. S., Lee, M. S., Lee, J. S., & Shim, C. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01403.x · Cited by 103
Yan, S., Li, Z., & Thiele, C. J. (2013) · Oncotarget · doi:10.18632/oncotarget.930 · Cited by 103
Chung, T. D., Yu, J. J., Kong, T., Spiotto, M. T., & Lin, J. M. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<1::aid-pros1>3.0.co;2-y · Cited by 102
Fenton, J. I., Hursting, S. D., Perkins, S. N., & Hord, N. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl018 · Cited by 102
LIF-Dependent Signaling: New Pieces in the Lego
Mathieu, M.-E., Saucourt, C., Mournetas, V., Gauthereau, X., Thézé, N., Praloran, V., Thiébaud, P., & Bœuf, H. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9261-7 · Cited by 101
Yakata, Y., Nakayama, T., Yoshizaki, A., Kusaba, T., Inoue, K., & Sekine, I. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.437 · Cited by 99
Yamashita, T., Honda, M., Nio, K., Nakamoto, Y., Yamashita, T., Takamura, H., Tani, T., Zen, Y., & Kaneko, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4210 · Cited by 99
Serum interleukin‐6 associated with hepatocellular carcinoma risk: A nested case–control study
Ohishi, W., COLOGNE, J. B., Fujiwara, S., Suzuki, G., Hayashi, T., Niwa, Y., Akahoshi, M., Ueda, K., Tsuge, M., & Chayama, K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28337 · Cited by 98
Kim, M. S., Louwagie, J., Carvalho, B. G., Droste, J. S. T. S., Park, H. L., Chae, Y. K., Yamashita, K., Liu, J.-W., Ostrow, K. L., Ling, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006555 · Cited by 98
HUANG, C., Yang, G., Jiang, T., Zhu, G., Li, H., & Qiu, Z. (2011) · Neoplasma · doi:10.4149/neo_2011_05_396 · Cited by 98
Songür, N., Kuru, B., Kalkan, F., Özdilekcan, Ç., Çakmak, H., & Hızel, N. (2004) · Tumori Journal · doi:10.1177/030089160409000207 · Cited by 96
Pollari, S., Leivonen, S., Perälä, M., Fey, V., Käkönen, S.-M., & Kallioniemi, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037361 · Cited by 95
Talar‐Wojnarowska, R., Gąsiorowska, A., Smolarz, B., Romanowicz‐Makowska, H., Kulig, A., & Malecka-Panas, E. I. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0390-z · Cited by 95
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
Dougan, M. L., Li, D., Neuberg, D. S., Mihm, M. C., Googe, P. B., Wong, K., & Dranoff, G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44796 · Cited by 95
Liao, W., Lin, J., Wu, C., Huang, S.-P., Lin, M., Wu, A. S.-H., Huang, Y.-J., & Wu, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1032 · Cited by 94
miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling
Collins, A. S., McCoy, C., Lloyd, A., O'Farrelly, C., & Stevenson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069090 · Cited by 94
Howlett, M., Giraud, A. S., Lescesen, H., Jackson, C. B., Kalantzis, A., van Driel, I. R., Robb, L. G., der Hoek, M. B. V., Ernst, M., Minamoto, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.003 · Cited by 93
Wu, C., Hsieh, C., Lin, C., Chen, W., Hong, J., & Chen, M. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0916-x · Cited by 93
Nakayama, T., Yoshizaki, A., Izumida, S., Suehiro, T., Miura, S., Uemura, T., Yakata, Y., Shichijo, K., Yamashita, S., & Sekin, I. (2007) · PubMed · Cited by 91
Lin, J., Wang, J., Chen, M., Chen, H.-C., Chang, T.-H., Su, B.-W., & Chang, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.003 · Cited by 91
de Groot, J., Liang, J., Kong, L.-Y., Wei, J., Piao, Y., Fuller, G. N., Qiao, W., & Heimberger, A. B. (2012) · Oncotarget · doi:10.18632/oncotarget.663 · Cited by 91
Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
McFarland, B. C., Ma, J., Langford, C. P., Gillespie, G. Y., Yu, H., Zheng, Y., Nozell, S. E., Huszar, D., & Benveniste, E. N. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0480 · Cited by 90
Ljungberg, B., Grankvist, K., & Rasmuson, T. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00179-2 · Cited by 89
Herrlinger, K. R., Witthoeft, T., Raedler, A., Bokemeyer, B., Krummenerl, T., Schulzke, J., Boerner, N. H., Kueppers, B., Emmrich, J., Mescheder, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00356.x · Cited by 88
Huang, W.-L., Yeh, H.-H., Lin, C.-C., Lai, W.-W., Chang, J.-Y., Chang, W.-T., & Su, W.-C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-309 · Cited by 86
Jiang, R., Jin, Z., Liu, Z., Sun, L., Wang, L., & Li, K. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256470 · Cited by 86
Tang, W., Yang, L., Yang, Y., Leng, S. X., & Elias, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5506 · Cited by 85
Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells
Onnis, B., Fer, N. D., Rapisarda, A., Perez, V. S., & Melillo, G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci59623 · Cited by 85
Ohe, Y., Podack, E. R., Olsen, K. J., Miyahara, Y., Miura, K., Saitô, H., Koishihara, Y., Ohsugi, Y., Ohira, T., Nishio, K., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.174 · Cited by 84
Shinriki, S., Jono, H., Ueda, M., Ota, K., Ota, T., Sueyoshi, T., Oike, Y., Ibusuki, M., Hiraki, A., Nakayama, H., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2935 · Cited by 84
Wang, Z.-G., Si, X., Xu, A., Meng, X.-Z., Gao, S.-L., Qi, Y.-J., Zhu, L., Li, T., Li, W., & Dong, L.-Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075788 · Cited by 83
Mankan, A., & Greten, F. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.601739 · Cited by 83
gp130: a promising drug target for cancer therapy
Xu, S., & Neamati, N. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.830105 · Cited by 83
Bellone, S., Watts, K., Cane', S., Palmieri, M., Cannon, M., Burnett, A., Roman, J., Pecorelli, S., & Santin, A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.03.016 · Cited by 81
Cytokines driving breast cancer stemness
Chin, A. R., & Wang, S. E. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.024 · Cited by 80
Yoshizaki, A., Nakayama, T., Yamazumi, K., Yakata, Y., Taba, M., & Sekine, I. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.869 · Cited by 80
Yang, S., Wang, S., Wu, C., Yeh, Y., Chai, C., Chunag, S.-C., Sheen, M., & Lee, K.-T. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.036970 · Cited by 80
Th, W., Chan, Y.-H., Chen, C., Kung, W.-H., Lee, Y.-S., Wang, S., Chang, T.-C., & Wang, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209498 · Cited by 79
Endogenous IL-11 Signaling Is Essential in Th2- and IL-13–Induced Inflammation and Mucus Production
Lee, C. G., Hartl, D., Matsuura, H., Dunlop, F., Scotney, P. D., Fabri, L., Nash, A. D., Chen, N., Tang, C., Chen, Q., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0053oc · Cited by 78
Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation
Bolin, C., Tawara, K., Sutherland, C., Redshaw, J. D., Aranda, P., Moselhy, J., Anderson, R. L., & Jorcyk, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912458284 · Cited by 77
Lee, J., Kim, J. C. K., Lee, S.-E., Quinley, C., Kim, H., Herdman, S., Corr, M., & Raz, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328831 · Cited by 76
García‐Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R., & Royuela, M. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02178.x · Cited by 76
Matsuda, T., Junicho, A., Yamamoto, T., Kishi, H., Korkmaz, K., Saatcioglu, F., Fuse, H., & Muraguchi, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4758 · Cited by 76
IL‐6 as an intracrine growth factor for renal carcinoma cell lines
Alberti, L., Thomachot, M. C., Bachelot, T., Ménétrier‐Caux, C., Puisieux, I., & Blay, J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20287 · Cited by 76
(1996) · PubMed · Cited by 75
Xu, W., Yi, M., Li, Q., Zhou, W., Cong, W., Yang, Y., Ning, B., Yin, C., Huang, Z., Wang, J., et al. (2013) · Hepatology · doi:10.1002/hep.26541 · Cited by 75
Weidle, U. H., Klostermann, S., Eggle, D., & Krüger, A. (2010) · PubMed · Cited by 75
Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis
Wang, H., Lafdil, F., Wang, L., Park, O., Yin, S., Niu, J., Miller, A. M., Sun, Z., & Gao, B. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.005 · Cited by 72
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Rose‐John, S., Mitsuyama, K., Matsumoto, S., Thaiss, W. M., & Scheller, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788489140 · Cited by 70
SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines
White, C. A., & Nicola, N. A. (2013) · JAK-STAT · doi:10.4161/jkst.25045 · Cited by 69
Circulating IL‐6 and sIL‐6R in Patients with Hepatocellular Carcinoma
Giannitrapani, L., Cervello, M., Soresi, M., Notarbartolo, M., Rosa, M., Virruso, L., D'Alessandro, N., & Montalto, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04093.x · Cited by 69
STAT3 in Epithelial Cells Regulates Inflammation and Tumor Progression to Malignant State in Colon
Nguyen, A., Wu, Y., Liu, Q., Wang, D., Nguyen, S. A., Loh, R., Pang, J., Friedman, K. A., Orlofsky, A., Augenlicht, L. H., et al. (2013) · Neoplasia · doi:10.1593/neo.13952 · Cited by 69
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report
Haftchenary, S., Avadisian, M., & Gunning, P. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328341185b · Cited by 68
Bhatia, M., Davenport, V. D., & Cairo, M. S. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600909115 · Cited by 68
Absolute requirement for STAT3 function in small-intestine crypt stem cell survival
Matthews, J. R., Sansom, O. J., & Clarke, A. R. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.77 · Cited by 68
Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population
Ognjanovic, S., Yamamoto, J. F., Saltzman, B. S., Franke, A. A., Ognjanovic, M., Yokochi, L. A., VOGT, T. M., Decker, R., & Marchand, L. L. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9540-7 · Cited by 68
Chang, K.-T., Tsai, C., Chiou, Y.-C., Chiu, C., Jeng, K.-S., & Huang, C. F. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00089.2005 · Cited by 68
Isolation and Characterization of the Human gp130 Promoter
O’Brien, C. A., & Manolagas, S. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.15003 · Cited by 67
He, Y., Sun, X., Huang, C., Long, X., Lin, X., Zhang, L., Lv, X., & Li, J. (2013) · Inflammation · doi:10.1007/s10753-013-9713-0 · Cited by 66
Inagaki-Ohara, K., Mayuzumi, H., Kato, S., Minokoshi, Y., Otsubo, T., Kawamura, Y. I., Dohi, T., Matsuzaki, G., & Yoshimura, A. (2012) · Oncogene · doi:10.1038/onc.2012.540 · Cited by 66
Xiao, H. Q., Yin, W., Ma, K., Gulen, M. F., Zhou, H., Sham, H. P., Jacobson, K., Vallance, B. A., & Li, X. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.043 · Cited by 66
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway
Ren, L., Wang, X., Dong, Z., Liu, J., & Zhang, S. (2013) · Medical Oncology · doi:10.1007/s12032-013-0634-4 · Cited by 65
Maeda, S., Hikiba, Y., Sakamoto, K., Nakagawa, H., Hirata, Y., Hayakawa, Y., Yanai, A., Ogura, K., Karin, M., & Omata, M. (2009) · Hepatology · doi:10.1002/hep.23199 · Cited by 65
Self-citationYu, G., He, G., Li, C., Tang, M., Grivennikov, S. I., Tsai, W.-T., Wu, M.-S., Hsu, C.-W., Tsai, Y., Wang, L. H.-C., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.032 · Cited by 65
Self-citationCytokine signalling via gp130 in gastric cancer
Howlett, M., Menheniott, T. R., Judd, L. M., & Giraud, A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.07.009 · Cited by 65
Kamohara, H., Ogawa, M., Ishiko, T., Sakamoto, K., & Baba, H. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.977 · Cited by 64
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Dijkgraaf, E. M., Welters, M. J. P., Nortier, J. W. R., van der Burg, S. H., & Kroep, J. R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802002797 · Cited by 64
Savarese, T. M., Campbell, C. L., McQuain, C., Mitchell, K., Guardiani, R., Quesenberry, P. J., & Nelson, B. E. (2002) · Cytokine · doi:10.1006/cyto.2002.1022 · Cited by 64
Punnonen, R., Teisala, K., Kuoppala, T. A., Bennett, B., & Punnonen, J. (1998) · Cancer · Cited by 63
Howlett, M., Judd, L. M., Jenkins, B. J., Gruta, N. L. L., Grail, D., Ernst, M., & Giraud, A. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.068 · Cited by 62
microRNAs as pharmacological targets in cancer
Soriano, A., Jubierre, L., Almazán-Moga, A., Molist, C., Roma, J. M., de Toledo, J. S., Gallego, S., & Segura, M. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.006 · Cited by 62
Yin, Z., Jin, F., Liu, T., Fu, E., Xie, Y., & Sun, R. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.03.053 · Cited by 62
Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma
Kuphal, S., Wallner, S., & Bosserhoff, A. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.06.012 · Cited by 61
JAK's SOCS: A Mechanism of Inhibition
Yoshimura, A., & Yasukawa, H. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.010 · Cited by 60
The Expression and Clinical Significance of pSTAT3, VEGF and VEGF-C in Pancreatic Adenocarcinoma
Huang, C., Huang, R. S., Chang, W., Jiang, T., Huang, K., Cao, J., Sun, X., & Qiu, Z. (2011) · Neoplasma · doi:10.4149/neo_2012_007 · Cited by 60
Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo
Geisterfer, M., Richards, C. D., Baumann, M., Fey, G. H., Gywnne, D., & Gauldie, J. (1993) · Cytokine · doi:10.1016/1043-4666(93)90017-y · Cited by 60
Haider, K. H., Idris, N. M., Kim, H. W., Ahmed, R. P. H., Shujia, J., & Ashraf, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq151 · Cited by 60
Smith, D. A., Kiba, A., Zong, Y., & Witte, O. N. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0238 · Cited by 60
Liang, H., Block, T. M., Wang, M., et al. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2012-00276 · Cited by 59
Liver macrophages contribute to pancreatic cancer-related cachexia
Martignoni (1994) · Oncology Reports · doi:10.3892/or_00000231 · Cited by 59
Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3
LAY, V., Yap, J., Sonderegger, S., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1486 · Cited by 59
An IL-6 link between obesity and cancer
Ghosh, S. (2013) · Frontiers in Bioscience · doi:10.2741/e628 · Cited by 57
Yamagiwa, Y., Meng, F., & Patel, T. C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.015 · Cited by 57
Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma
Lee, T. K., Cheung, V. C. H., & Ng, I. O. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.001 · Cited by 57
c‐Met signaling promotes IL‐6‐induced myeloma cell proliferation
Hov, H., Tian, E., Holien, T., Holt, R. U., Våtsveen, T. K., Fagerli, U., Waage, A., Børset, M., & Sundan, A. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01212.x · Cited by 54
Mansell, A. S., & Jenkins, B. J. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.007 · Cited by 54
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
Chopra, V., Dinh, T. V., & Hannigan, E. V. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050045 · Cited by 54
Correlation Analysis of JAK-STAT Pathway Components on Prognosis of Patients with Prostate Cancer
Liu, X., He, Z., Li, C., Huang, G., Ding, C., & Liu, H. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9410-y · Cited by 53
IL-6 activates STAT5 in T cells
Tormo, A. J., Letellier, M.-C., Sharma, M., Elson, G., Crabé, S., & Gauchat, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.002 · Cited by 53
Castrilli, G., Tatone, D., Diodoro, M. G., Rosini, S., Piantelli, M., & Musiani, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.152 · Cited by 53
IL-11: A Prominent Pro-Tumorigenic Member of the IL-6 Family
Grivennikov, S. I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.018 · Cited by 53
Ng, G., Winder, D. M., Muralidhar, B., Gooding, E. L., Roberts, I., Pett, M. R., Mukherjee, G., Huang, J., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2184 · Cited by 52
Underhill-Day, N., & Heath, J. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1766 · Cited by 52
Timme, S., Ihde, S., Fichter, C. D., Waehle, V., Bogatyreva, L., Atanasov, K., Kohler, I., Schöpflin, A., Geddert, H., Faller, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.298 · Cited by 52
Expression of the interleukin 6 receptor in primary renal cell carcinoma.
Costes, V., Liautard, J., Picot, M., Robert, M., Lequeux, N., Brochier, J., Baldet, P., & Rossi, J. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.10.835 · Cited by 52
Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate
Wang, L., Chow, K.-C., & Wu, C.-W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690571 · Cited by 52
Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells
Shin, H. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1447 · Cited by 52
Necula, L. G., Chivu‐Economescu, M., Stanciulescu, E.-L., Bleoţu, C., Dima, S., Alexiu, I., Dumitru, A., Constantinescu, G., Popescu, I., & Diaconu, C. C. (2012) · PubMed · Cited by 52
García‐Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R., & Royuela, M. (2008) · Cancer Investigation · doi:10.1080/07357900701638491 · Cited by 51
Leukemia Inhibitory Factor Binds to Human Breast Cancer Cells and Stimulates Their Proliferation
Estrov, Z. E., Samal, B. B., LaPushin, R., Kellokumpu‐Lehtinen, P., Şahin, A. A., Kurzrock, R., Talpaz, M., & Aggarwal, B. B. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.905 · Cited by 51
IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice
Visperas, A., Do, J., Bulek, K., Li, X., & Min, B. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.82 · Cited by 51
STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1
Wang, Z., Zhu, S., Shen, M., Liu, J., Wang, M., Li, C., Wang, Y., Deng, A., & Mei, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs361 · Cited by 51
Huang, Y., Yang, H., Hsu, Y.-F., Chiu, P.-T., Ou, G., & Hsu, M. (2013) · Angiogenesis · doi:10.1007/s10456-013-9386-1 · Cited by 49
Liu, J., Spence, M. J., Wallace, P. M., Forcier, K., Hellström, I., & Vestal, R. E. (1997) · PubMed · Cited by 49
Łukaszewicz‐Zając, M., Mroczko, B., Kozłowski, M., Nikliński, J., Laudanski, J., & Szmitkowski, M. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01242.x · Cited by 48
Shin, J. E., Park, S. H., & Jang, Y. K. (2010) · Molecules and Cells · doi:10.1007/s10059-011-0020-z · Cited by 48
Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in Small Cell Lung Cancer
Zhao, X., Sun, X. W., & Li, X. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.6.2873 · Cited by 48
IL-6 is a survival prognostic factor in renal cell carcinoma
Thiounn, N., Pagès, F., FLAM, T. A., Tartour, É., Mosseri, V., Zerbib, M., Beuzeboc, P., Deneux, L., Fridman, W. H., & Debré, B. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00036-9 · Cited by 47
Dhingra, K., Şahin, A. A., Emami, K., Hortobágyi, G. N., & Estrov, Z. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005942923757 · Cited by 47
You, Z., Xu, D., Ji, J., Guo, W., Zhu, W., & He, J. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0774-6 · Cited by 46
Okaya, A., Kitanaka, J., Kitanaka, N., Satake, M., Kim, Y., Terada, K., Sugiyama, T., Takemura, M., Fujimoto, J., Terada, N., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62292-4 · Cited by 46
Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms
Bhagwat, N., Levine, R. L., & Koppikar, P. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1353-5 · Cited by 46
Makuuchi, Y., Honda, K., Osaka, Y., Kato, K., Kojima, T., Daiko, H., Igaki, H., Ito, Y., Hoshino, S., 立花, 慎., et al. (2013) · Cancer Science · doi:10.1111/cas.12187 · Cited by 45
Oncostatin M Down-regulates Basal and Induced Cytochromes P450 in Human Hepatocytes
Guillén, M. I., Donato, M. T., Jover, R., Castell, J. V., Fabra, R., Trullenque, R., & Gómez-Lechón, M. J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37388-4 · Cited by 44
Sales, K. J., Grant, V., Cook, I. H., Maldonado‐Pérez, D., Anderson, R. A., Williams, A. R. W., & Jabbour, H. N. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090403 · Cited by 44
Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma
Benson, D. D., Meng, X., Fullerton, D. A., Moore, E. E., Lee, J. H., Ao, L., Silliman, C. C., & Barnett, C. C. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00320.2011 · Cited by 44
Yamazumi, K., Nakayama, T., Kusaba, T., Wen, C. Y., Yoshizaki, A., Yakata, Y., Nagayasu, T., & Sekine, I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.317 · Cited by 44
Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice
Pini, M., Rhodes, D., & Fantuzzi, G. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.015 · Cited by 42
SCHOPPMANN, S. F., Jesch, B., Friedrich, J., Jomrich, G., Maroske, F., & Birner, P. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9475-3 · Cited by 42
Seavey, M. M., Lu, L. D., Stump, K. L., Wallace, N. H., Hockeimer, W., O’Kane, T. M., Ruggeri, B., & Dobrzański, P. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0951 · Cited by 42
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Chalaris, A., Schmidt‐Arras, D., Yamamoto, K., & Rose‐John, S. (2012) · Digestive Diseases · doi:10.1159/000341698 · Cited by 42
Signal transducer and activator of transcription-3 and breast cancer prognosis.
Sato, T., Neilson, L. M., Peck, A. R., Liu, C., Tran, T. H., Witkiewicz, A., Hyslop, T., Nevalainen, M. T., Sauter, G., & Rui, H. (2011) · PubMed · Cited by 41
Interleukin-6 and obesity: the crosstalk between intestine, pancreas and liver
El-Kadre, L. J., & TINOCO, A. C. D. A. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32836410e6 · Cited by 41
Transcriptional regulation of the interleukin-11 gene by oncogenic Ras
Shin, S. Y., Choi, C., Lee, H. G., Lim, Y. C., & Lee, Y. H. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs297 · Cited by 41
Guimbaud, R., Abitbol, V., Bertrand, V., Quartier, G., Chauvelot‐Moachon, L., Giroud, J., Couturier, D., & Chaussade, D. C. (1998) · PubMed · Cited by 39
Regulation of drug transporter expression by oncostatin M in human hepatocytes
Vée, M. L., Jouan, E., Stieger, B., Lecureur, V., & Fardel, O. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.017 · Cited by 39
STAT3 as a prognostic marker in human gastric cancer
Jackson, C. B., & Giraud, A. S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05822.x · Cited by 38
Xiang, Z., Zeng, Z.-C., Fan, J., Tang, Z., & Zeng, H. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1413-y · Cited by 38
Eldesoky, A., Shoma, A. M., Mosaad, Y., & Elhawary, A. (2011) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.80378 · Cited by 38
Obesity Promotes Liver Carcinogenesis via Mcl-1 Stabilization Independent of IL-6Rα Signaling
Gruber, S. G., Straub, B. K., Ackermann, P., Wunderlich, C. M., Mauer, J., Seeger, J. M., Büning, H., Heukamp, L. C., Kashkar, H., Schirmacher, P., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.023 · Cited by 37
Therapeutic Blockade of Interleukin-6 in Chronic Inflammatory Disease
Yamamoto, K., & Rose‐John, S. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.11 · Cited by 36
Interleukin-11 Receptor Expression in Primary Ovarian Carcinomas
Campbell, C. L., Guardiani, R., Ollari, C., Nelson, B. E., Quesenberry, P. J., & Savarese, T. M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6064 · Cited by 36
Jin, C., Wang, A., CHEN, J., Liu, X.-M., & Wang, G. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.651 · Cited by 35
Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
Kanda, J., Uchiyama, T., Tomosugi, N., Higuchi, M., Uchiyama, T., & Kawabata, H. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0443-x · Cited by 35
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model
Murakami, T., Takigawa, N., Ninomiya, T., Ochi, N., Yasugi, M., Honda, Y., Kubo, T., Ichihara, E., Hotta, K., Tanimoto, M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.10.011 · Cited by 35
Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican
Zhang, Z., Zhang, J., Miao, L., Liu, K., Yang, S., Pan, C., & Jiao, B. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.3579 · Cited by 35
Gao, Y., Xiang, Z., Zhou, L., Wu, Z., Fan, J., Zeng, H., & Zeng, Z. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1370-4 · Cited by 33
Ruxolitinib: In the Treatment of Myelofibrosis
Yang, L. P. H., & Keating, G. M. (2012) · Drugs · doi:10.2165/11209340-000000000-00000 · Cited by 33
Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells
Zhang (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000178 · Cited by 31
Targeting IL-11 signaling in colon cancer
Ernst, M., & Putoczki, T. L. (2013) · Oncotarget · doi:10.18632/oncotarget.1410 · Cited by 29
Yap, J., Salamonsen, L. A., Jobling, T. W., Nicholls, P. K., & Dimitriadis, E. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-63 · Cited by 29
The role of miRNAs in cytokine signaling
McCoy, C. E. (2011) · Frontiers in bioscience · doi:10.2741/3845 · Cited by 28
Rincón, M., Broadwater, G., Harris, L. N., Crocker, A. M., Weaver, D. L., Dressler, L., Berry, D. A., Sutton, L., Michaelson, R. A., Messino, M. J., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9251-7 · Cited by 28
Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130)
Geisterfer, M., Richards, C. D., & Gauldie, J. (1995) · Cytokine · doi:10.1006/cyto.1995.0068 · Cited by 27
Tumor growth and food intake in interleukin-6 gene knock-out mice
Molotkov, A., Satoh, M., & Tohyama, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00182-7 · Cited by 27
The role of interleukin-6 in gynaecological malignancies
Coward, J. I. G., & Kulbe, H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.005 · Cited by 26
Control of gp130 expression by the mitogen-activated protein kinase ERK2
Bonito, N. A., Drechsler, J., Stöcker, S., do Carmo, C. R., Seckl, M. J., Hermanns, H. M., & Costa‐Pereira, A. P. (2013) · Oncogene · doi:10.1038/onc.2013.159 · Cited by 26
Crosstalk between TLR5 and Notch1 signaling in epithelial cells during intestinal inflammation
Aziz, M., Ishihara, S., Ansary, M. U., Sonoyama, H., Tada, Y., Oka, A., Kusunoki, R., Tamagawa, Y., Fukuba, N., Mishima, Y., et al. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1501 · Cited by 26
Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer
Ai, T., Wang, Z., Zhang, M., Zhang, L., Wang, N., Li, W., & Song, L. (2012) · The International Journal of Biological Markers · doi:10.5301/jbm.2012.9146 · Cited by 25
STAT3 & Cytochrome P450 2C9: A novel signaling pathway in liver cancer stem cells
Myung, S. J., Yoon, J., & Yu, S. J. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.08.011 · Cited by 25
Lee, J., Park, K., Alberobello, A. T., Kallakury, B., Weng, M., Wang, Y., & Giaccone, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1110 · Cited by 25
Kausar, T., Sharma, R., Hasan, M. R., Saraya, A., Chattopadhyay, T. K., Gupta, S. D., & Ralhan, R. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0011-2 · Cited by 24
Bay, J. M., Patterson, B. K., & Teng, N. N. H. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/463081 · Cited by 24
Wu, W., Li, J., Wu, Z., Zhang, C., Meng, X.-L., & Lobie, P. E. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.254 · Cited by 23
Poncet, N., Guillaume, J., & Mouchiroud, G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.009 · Cited by 19
Interleukin-6 (IL-6) production in carcinoma of the cervix
Takanol, H., Harigaya, K., Ishii, G., Sugaya, Y., Soeta, S., Nunoyamal, T., Shirasawa, H., Shimizu, K., Tokita, H., Simizu, B., et al. (1996) · Archives of Gynecology and Obstetrics · doi:10.1007/bf01370929 · Cited by 19
Peterson, H., Dawud, R. A., Garg, A. D., Wang, Y., Vilo, J., Xénarios, I., & Adjaye, J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00303 · Cited by 17
Wu, D., Tao, J., Ding, J., Qü, P., Lü, Q., & Zhang, W. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1199 · Cited by 17
Serum Interleukin-11 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer
Furuya, Y., Nishio, R., Junicho, A., Nagakawa, O., & Fuse, H. (2005) · International Urology and Nephrology · doi:10.1007/s11255-004-6086-1 · Cited by 14
Cited by
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Self-citationCancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Obesity and inflammation: the linking mechanism and the complications
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.58928 · Cited by 1,982
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
“STAT3 activation promotes neoplastic cell proliferation and survival, and multiple tumor cell lines exhibit IL-6- or STAT3-dependent chemoresistance in vitro (Taniguchi and Karin, 2014; Yu et al., 2014).”
Metadata
- Authors
- Taniguchi, K., & Karin, M.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 26
- Issue
- 1
- Pages
- 54-74
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2006371195
- Cited by
- 716
- References
- 402
- FWCI
- 25.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.